Sam Lerman

Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome

Maria Fleseriu, Beverly M. K. Biller, James W. Findling et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 484 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Inhibition of Parathyroid Hormone Secretion by 25-Hydroxycholecalciferol and 24,25-Dihydroxycholecalciferol in the Dog

Janet M. Canterbury, Sam Lerman, Alice J. Claflin et al. · Journal of Clinical Investigation · 1978 · 146 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Efficacy of Inhaled Insulin in Patients With Type 2 Diabetes not Controlled With Diet and Exercise

Ralph A. DeFronzo, Richard M. Bergenstal, William T. Cefalu et al. · Diabetes Care · 2005 · 135 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +11